RavenQuest BioMed Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '25 Dec 29, 2025	Oct '18 Oct 31, 2018	Oct '17 Oct 31, 2017	Oct '16 Oct 31, 2016	Oct '15 Oct 31, 2015	Oct '14 Oct 31, 2014
Market Capitalization	0	59	-	-	-	-
Enterprise Value	-	67	-	-	-	-
Last Close Price	0.00	0.52	-	-	-	-
PS Ratio	0.00	61.42	-	-	-	-
PB Ratio	0.00	3.45	-	-	-	-
P/TBV Ratio	0.00	19.00	-	-	-	-
EV/Sales Ratio	-	70.39	-	-	-	-
Debt / Equity Ratio	0.72	0.59	0.03	-0.19	-0.14	-0.14
Debt / EBITDA Ratio	-	-	-	-	-	0.13
Net Debt / Equity Ratio	0.68	0.58	-0.42	-0.18	-0.14	-0.10
Net Debt / EBITDA Ratio	-1.42	-1.20	5.29	-1.16	-0.72	0.10
Net Debt / FCF Ratio	-1.73	-0.55	1.26	-2.56	-2.56	-0.84
Asset Turnover	0.03	0.05	0.03	-	-	-
Quick Ratio	0.30	0.67	3.15	0.01	0.01	0.03
Current Ratio	0.49	1.14	3.24	0.01	0.01	0.03
Return on Equity (ROE)	-112.46%	-203.40%	-92.75%	-	-	-
Return on Assets (ROA)	-18.85%	-34.05%	-8.55%	-527.91%	-401.59%	-176.73%
Return on Capital Employed (ROCE)	-40.70%	-35.50%	-7.90%	15.90%	19.10%	25.90%
Earnings Yield	-13523337.36%	-39.48%	-	-	-	-
FCF Yield	-3389962.64%	-30.27%	-	-	-	-
Buyback Yield / Dilution	-53.47%	-180.28%	-12.00%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.